Appointment registration for Corona vaccination Rhineland-Palatinate

Under the following circumstances, you CANNOT currently get vaccinated against coronavirus at the Vaccination Center:

• You have an acute illness requiring treatment, especially a febrile infectious disease
• Age limit: generally younger than 5 years
• You are pregnant in the first trimester (see also question: Can I get vaccinated despite being pregnant?)

The 1st booster vaccination is possible three months after completion of the vaccination series according to the recommendation of the STIKO. This applies to vaccinations with the vaccines from BioNTech, Moderna, AstraZeneca and Johnson & Johnson. Registration for a 1st booster vaccination is possible after only two months. An appointment is then given for a period when it has been 3 months since the completion of the vaccination series, and thus the acquisition of full vaccination protection.

The STIKO recommends a 2nd booster vaccination for people over 70 years of age, residents and in care facilities, people with immune deficiencies, as well as those working in medical and care facilities (especially those with direct patient and resident contact). The 2nd booster vaccination should be given to groups of people at risk of health problems earliest 3 months after the 1st booster vaccination with an mRNA vaccine. Personnel in medical and care facilities should receive the 2nd booster vaccination no earlier than 6 months.

On September 10, 2021, after extensive deliberation and evaluation of the available evidence, the Standing Commission on Vaccination advocated in a new draft decision for COVID-19 vaccination of previously unvaccinated or incompletely vaccinated pregnant women from the 2nd trimester of pregnancy and of unvaccinated or incompletely vaccinated breastfeeding women with two doses of an mRNA vaccine.

The recommendation is based on a systematic review of data that have become available in recent weeks on the risk of severe COVID-19 events in pregnancy and on the effectiveness and safety of COVID-19 vaccination in pregnant and breastfeeding women.

Please note that vaccination with Nuvaxovid is not recommended during pregnancy and lactation.

A tabular overview of the recommended vaccination schedule (basic immunization and booster vaccination) after SARS-CoV-2 infection in immunocompromised individuals can be found in Table 7 of the 18th update of the STIKO recommendation.

STIKO recommends administration of one vaccine dose as part of basic immunization for unvaccinated immunocompromised individuals 12 years of age and older and for 5- to 11-year-old children with preexisting conditions who have undergone confirmed SARS-CoV-2 infection*. If infection was confirmed by PCR test, vaccination should be given at least 3 months after illness.

If the infection was confirmed by serological detection of specific antibodies in a blood sample, vaccination can be given as early as 4 weeks after laboratory diagnosis. In persons with immunodeficiency, it must be decided on a case-by-case basis whether a single dose of vaccine is sufficient or whether a complete vaccination series should be administered. Children without preexisting conditions who have already experienced laboratory-diagnosed SARS-CoV-2 infection should not be vaccinated for the time being.

Individuals who have had confirmed SARS-CoV-2 infection less than 4 weeks apart from the previous vaccination after the 1st vaccine dose will receive a 2nd vaccine dose with an interval of 3 months or more from the infection as part of basic immunization. If serologic evidence of SARS-CoV-2 infection is present, administration of a vaccine dose may also be given as early as 4 weeks apart from laboratory diagnosis. If the SARS-CoV-2 infection has occurred at an interval of 4 or more weeks from the previous 1-time vaccination, no further vaccination is necessary for basic immunization.

For the First Booster Vaccination:

• Persons who have experienced SARS-CoV-2 infection and received a dose of vaccine at least 4 weeks apart thereafter to enhance immune protection should receive a booster vaccination at an interval of at least 3 months after the previous vaccination.
• Individuals who have undergone SARS-CoV-2 infection after COVID-19 vaccination (regardless of the number of vaccine doses for basic immunization) should also receive booster vaccination at an interval of at least 3 months after infection according to the STIKO recommendation.
• However, if the SARS-CoV-2 infection occurs at an interval of at least 3 months after the previous vaccine dose and the basic immunization consisted of 2 vaccine doses, no booster vaccination is necessary until further notice.

For the time being, a second booster vaccination is not recommended for individuals who have experienced SARS-CoV-2 infection after receiving the first booster vaccination.

* Detection of confirmed, passed-through SARS-CoV-2 infection can be done by direct pathogen detection (PCR) at the time of infection or by detection of specific antibodies that prove passed-through infection. The laboratory diagnostic findings should have been obtained in a laboratory working in accordance with the guidelines of the German Medical Association for quality assurance of laboratory medical examinations (RiLiBÄK) or accredited in accordance with DIN EN ISO 15189.
Please bring a corresponding proof document with you to your vaccination appointment at the vaccination center.

Vaccination of children and adolescents aged 5 to 11 years is possible in the following vaccination centers in Rhineland-Palatinate:

• Vaccination center Alzey-Worms
• Vaccination center Bad Dürkheim
• Vaccination center Bernkastel-Wittlich
• Vaccination center Birkenfeld
• Vaccination center Germersheim/Südpfalz
• Vaccination center Kaiserslautern
• Vaccination center Koblenz
• Vaccination center Ludwigshafen
• Vaccination center Mainz
• Vaccination center Neustadt
• Vaccination center Rhein-Lahn-Kreis
• Vaccination center Rhein-Pfalz-Kreis
• Vaccination center Speyer

Please select one of these vaccination centers to register if you are registering a child under the age of 12 for vaccination.

Children and adolescents aged 12-17 years can be registered for vaccination and the first booster vaccination in all vaccination centers named in the registration form. Registration for the second booster vaccination is only possible for certain groups of people, according to the STIKO communication. Registration is possible from the age of 16.

For vaccination of children and adolescents up to and including 15 years of age, the consent of the vaccinated person is required, as well as the accompaniment of at least one custodial person who consents in writing to the vaccination (for documentation purposes) and assures that he or she is appropriately authorized to do so by any co-custodial persons. For adolescents over 16 years of age, written parental consent is required. You can download this here.

Please note that you enter the data of your child for registration in the registration form.

You can register a maximum of 5 people for a group appointment via the form. It is also possible to register people for different types of vaccination appointments (first, second and booster vaccinations). However, it should be noted that the necessary intervals for second and booster vaccinations are taken into account in the appointment allocation process. If, for example, the possible date for a booster vaccination for person 1 of the group is further in the future than for another person 2 of the group, then both persons will receive an appointment taking into account the earliest possible date for person 1, so that the required intervals are observed in each case.

In addition, it is important to note: special immunization days are offered at immunization centers for children 5-11 years of age. If individuals 12 years and older are registered in a group together with a 5-11 year old child, the entire group can be vaccinated exclusively on these days at the vaccination center. Thus, longer wait times for an appointment for the entire group may be expected.

Please note that if you wish to be vaccinated with Novavax as part of a group registration, all group members must indicate that they wish to be vaccinated with this vaccine. Registration for a group appointment is only possible if all group members choose this vaccine, or no group member chooses it.

You can only register for individual appointments (first vaccination or second vaccination or booster) and will receive an e-mail and optionally an SMS as soon as an appointment has been allocated for you at the selected vaccination center.

Vaccination centers and vaccination sites have at their disposal mRNA vaccines, vector vaccines and, since February 2022, the protein vaccine Nuvaxovid.
Please note that there is generally no choice of vaccine. The selection of the vaccine suitable for you will be made, if necessary on site, according to the applicable recommendations regarding age, vaccine combinations, pre-existing diseases and other parameters.

However, if you wish to receive the newly approved protein vaccine Nuvaxovid from the manufacturer Novavax, you can indicate this in the registration process for your vaccination appointment. Individuals who do not indicate nuvaxovid vaccine as a request on the registration form will receive a different vaccine.
Combinations of nuvaxovid and mRNA or vector vaccines are possible under certain circumstances. For more information, see "What information should be noted for vaccination with the Novavax vaccine?"

Since December 20, 2021, the protein vaccine Nuvaxovid of the manufacturer Novavax has been approved by the EU Commission. If you wish to be vaccinated with this vaccine, please indicate this in the registration form.

If you decide for a first vaccination with the vaccine Nuvaxovid, you will receive the first and the second vaccination with this vaccine. The second vaccination should be given three to four weeks apart from the first vaccination.

A second vaccination with Nuvaxovid after an initial vaccination with another vaccine is only possible if you received the Janssen vaccine from Johnson & Johnson at the initial vaccination. A combination with an mRNA vaccine in the course of basic immunization is not intended according to current STIKO recommendations.

According to current regulations, Nuvaxovid is not used as a booster vaccine because there is no corresponding approval. However, according to STIKO, Nuvaxovid may be offered as a booster vaccine in individual cases after medical education if contraindications to mRNA-COVID-19 vaccines exist. Please bring an appropriate medical certificate with you to the vaccination appointment.

To cancel your vaccination appointment, please using the form.

The Federal Ministry of Health provides detailed information on the Corona virus in Arabic, Spanish, Turkish and Russian. You can find these here.

Before your vaccination, you will receive the educational sheet that contains all the information about the vaccination. If you would like to read this in a language other than German please click here.